Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

BTX

Brooklyn ImmunoTherapeut... (BTX)

Brooklyn ImmunoTherapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:AMEX:BTX
DatumZeitQuelleÜberschriftSymbolFirma
11/05/202322h35Edgar (US Regulatory)Quarterly Report (10-q)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
10/05/202312h02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
05/05/202313h02Edgar (US Regulatory)Annual Report to Security Holders (ars)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
05/05/202313h02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
05/05/202313h01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
05/05/202312h31Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
25/04/202315h02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
20/04/202322h31Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
11/04/202313h31Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
04/04/202323h15Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
04/04/202323h05Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
21/03/202313h39Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
06/03/202322h06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
26/01/202322h32Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
10/01/202322h31Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
04/01/202314h36Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
20/12/202222h31Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
16/12/202223h01Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
14/12/202222h31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
07/12/202200h52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
06/12/202222h31Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
05/12/202223h21Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
05/12/202212h04Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
02/12/202223h01Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
22/11/202222h07Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
14/11/202222h57Edgar (US Regulatory)Quarterly Report (10-q)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
24/10/202222h32Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
14/10/202222h34Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
11/10/202214h31Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
23/09/202222h32Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
 Showing the most relevant articles for your search:AMEX:BTX

Kürzlich von Ihnen besucht

Delayed Upgrade Clock